Vitamin E in humans: Demand and delivery

被引:371
作者
Traber, MG [1 ]
Sies, H [1 ]
机构
[1] UNIV DUSSELDORF, INST PHYSIOL CHEM 1, D-40001 DUSSELDORF, GERMANY
关键词
tocopherol; lipoproteins; chylomicrons; VLDL; LDL; HDL; tocopherol transfer protein; ataxia with vitamin E deficiency;
D O I
10.1146/annurev.nu.16.070196.001541
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
How much vitamin E is enough? An established use of supplemental vitamin E in humans is in the prevention and therapy of deficiency symptoms. The cause of vitamin E deficiency, characterized by peripheral neuropathy and ataxia, is usually malabsorption-a result of fat malabsorption or genetic abnormalities in lipoprotein metabolism. Genetic abnormalities in the hepatic alpha-tocopherol transfer protein also cause vitamin E deficiency-defects in this protein cause an impairment in plasma vitamin E transport. Impaired delivery of vitamin E to tissues, thereby, results in deficiency symptoms. Also discussed is the use of supplemental vitamin E in chronic diseases such as ischemic heart disease, atherosclerosis, diabetes, cataracts, Parkinson's disease, Alzheimer's disease, and impared immune function, as well as in subjects receiving total parenterol nutrition. In healthy individuals, a daily intake of about 15-30 mg of alpha-tocopherol is recommended to obtain ''optimal plasma alpha-tocopherol concentrations'' (30 mu M or greater).
引用
收藏
页码:321 / 347
页数:27
相关论文
共 158 条
[1]   ALZHEIMERS AND PARKINSONS-DISEASE - BRAIN LEVELS OF GLUTATHIONE, GLUTATHIONE DISULFIDE, AND VITAMIN-E [J].
ADAMS, JD ;
KLAIDMAN, LK ;
ODUNZE, IN ;
SHEN, HC ;
MILLER, CA .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1991, 14 (03) :213-226
[2]  
[Anonymous], 1991, OXIDATIVE STRESS OXI
[3]  
[Anonymous], 1989, REC DIET ALL
[4]   HUMAN ALPHA-TOCOPHEROL TRANSFER PROTEIN - CDNA CLONING, EXPRESSION AND CHROMOSOMAL LOCALIZATION [J].
ARITA, M ;
SATO, Y ;
MIYATA, A ;
TANABE, T ;
TAKAHASHI, E ;
KAYDEN, HJ ;
ARAI, H ;
INOUE, K .
BIOCHEMICAL JOURNAL, 1995, 306 :437-443
[5]   VITAMIN-E PROTECTS NERVE-CELLS FROM AMYLOID BETA-PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, J ;
COLE, GM ;
SCHUBERT, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) :944-950
[6]  
BELAL S, 1995, CLIN NEUROSCI, V3, P39
[7]  
BENDICH A, 1990, ADV EXP MED BIOL, V262, P35
[8]   SAFETY OF ORAL INTAKE OF VITAMIN-E [J].
BENDICH, A ;
MACHLIN, LJ .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1988, 48 (03) :612-619
[9]   LOCALIZATION OF FRIEDREICH ATAXIA PHENOTYPE WITH SELECTIVE VITAMIN-E-DEFICIENCY TO CHROMOSOME-8Q BY HOMOZYGOSITY MAPPING [J].
BENHAMIDA, C ;
DOERFLINGER, N ;
BELAL, S ;
LINDER, C ;
REUTENAUER, L ;
DIB, C ;
GYAPAY, G ;
VIGNAL, A ;
LEPASLIER, D ;
COHEN, D ;
PANDOLFO, M ;
MOKINI, V ;
NOVELLI, G ;
HENTATI, F ;
BENHAMIDA, M ;
MANDEL, JL ;
KOENIG, M .
NATURE GENETICS, 1993, 5 (02) :195-200
[10]   FRIEDREICH ATAXIA PHENOTYPE NOT LINKED TO CHROMOSOME-9 AND ASSOCIATED WITH SELECTIVE AUTOSOMAL RECESSIVE VITAMIN-E-DEFICIENCY IN 2 INBRED TUNISIAN FAMILIES [J].
BENHAMIDA, M ;
BELAL, S ;
SIRUGO, G ;
BENHAMIDA, C ;
PANAYIDES, K ;
IONANNOU, P ;
BECKMANN, J ;
MANDEL, JL ;
HENTATI, F ;
KOENIG, M ;
MIDDLETON, L .
NEUROLOGY, 1993, 43 (11) :2179-2183